Anseong Center

Leveraging Daewoong Group's accumulated technological prowess and manufacturing competitiveness, this facility is responsible for Daewoong Bio's finished product production. We produce pharmaceuticals for a wide range of medical applications, including the nervous system, endocrine system, digestive system, and circulatory system. Key products include Gliatamin, Beacept, Atorvastatin, Beasta, Clarithromycin, Loxoprofen, Vforge, Kratin, Fosidapa, Bearcoxib, Bearazaltan, and Nexiquin.
We operate a step-by-step quality assessment and assurance system, from raw material receipt to finished product shipment. We ensure the highest level of quality by validating all processes, including equipment, manufacturing, testing, personnel, and environmental systems.


We maximize customer satisfaction with rapid delivery through a 24 7 full-operation system, by providing order and delivery information, and offering customized services. By leveraging the value of the Daewoong brand, we simultaneously secure competitiveness in both quality and price, while maintaining a competitive edge in the global market.
Daewoong Bio's Anseong Center has an annual production capacity of 600 million tablets.

